Trial Profile
A Comparison of Combination Antiemetic Regimen for Prevention of PONV in Breast Surgery Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2022
Price :
$35
*
At a glance
- Drugs Aprepitant (Primary) ; Dexamethasone (Primary) ; Ondansetron (Primary)
- Indications Postoperative nausea and vomiting
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme Corp.
- 19 Oct 2011 Results presented at the 2011 Annual Meeting of the American Society of Anesthesiologists.
- 12 Sep 2008 New trial record.